MediPharm Labs Signs Committed Term Sheet for $20 Million Debt Facility With Schedule 1 Bank

Financing to Support Accelerated Growth TORONTO, May 15, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs”) a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased to announce that its wholly-owned subsidiary, MediPharm Labs Inc. (“MediPharm”), has signed a committed term sheet for a $20 million senior secured revolving […]

READ MORE: https://www.newcannabisventures.com/medipharm-labs-signs-committed-term-sheet-for-20-million-debt-facility-with-schedule-1-bank/